Suchitra Sundaram, MD, shares that ASH 2025 presented major advances in chronic lymphocytic leukemia (CLL) across both time‑limited and continuous treatment strategies, and emphasized the growing role ...
Combining CIT with BTKi may enhance complete response rates and progression-free survival in RT-DLBCL compared to CIT alone. The study observed no statistically significant difference in overall ...
Zanubrutinib demonstrates prolonged progression-free survival in relapsed/refractory CLL/SLL, with a median PFS of 52.5 months and 49.9 months for patients with del17p. The ALPINE trial confirms ...
Two years after premiering a 13-minute documentary about three eczema patients, Abbvie has again teamed with branded entertainment firm Passion Point Collective, this time for a 16-minute documentary ...
Florida Rep is one of Lee County and Southwest Florida’s most important cultural and educational institutions and has been named “Best Performing Arts Group” numerous times by Gulfshore Life Magazine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results